Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds ( Surgical Wounds and Burns)), By End User (Hospital, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI28419 | Publish Date: April 2024 | No. of Pages: 180

Global Wound Care Biologics Market Companies

  • Smith & Nephew Plc.
  • Organogenesis, Inc.
  • Integra Lifesciences Holdings Corporation
  • Skye Biologics, Inc.
  • Alphatec Holdings, Inc.
  • Solsys Medical LLC
  • Amino Technology LLC
  • Osiris Therapeutics, Inc.

Recent News:

  • In July 2022, StimLabs, LLC, which aims to improve patient care by developing novel patient-specific interventions, recently launched Enverse, a placental membrane product that can be used to treat acute and chronic wounds.
  •  In March 2022, The Premier Graft Program is WoundGenex's way of making it easier for clinicians to access the best allograft products in the industry through a strategic partnership with MiMedx Group, Inc., a leading placental biologics company.